Apriso

Apriso Corporation is a leading provider of manufacturing operations management (MOM) software solutions, primarily known for its flagship FlexNet platform. While not a drug developer, the company is a critical technology partner for the life sciences, pharmaceutical, and medical device industries, enabling global manufacturing synchronization and regulatory compliance. Its solutions allow manufacturers to manage production, quality, and supply chain operations in real-time across multiple global sites. Apriso's technology is particularly valued for its ability to ensure adherence to strict regulatory standards such as 21 CFR Part 11. In 2013, the company was acquired by Dassault Systèmes for approximately $205 million and integrated into the DELMIA brand.